|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
3
|
Hardisson D: Molecular pathogenesis of
head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol.
260:502–508. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gil Z and Fliss DM: Contemporary
management of head and neck cancers. Isr Med Assoc J. 11:296–300.
2009.PubMed/NCBI
|
|
5
|
Su T, Liu H and Lu S: Cloning and
identification of cDNA fragments related to human esophageal
cancer. Zhonghua Zhong Liu Za Zhi. 20:254–257. 1998.(In
Chinese).
|
|
6
|
Yue CM, Deng DJ, Bi MX, Guo LP and Lu SH:
Expression of ECRG4, a novel esophageal cancer-related gene,
downregulated by CpG island hypermethylation in human esophageal
squamous cell carcinoma. World J Gastroenterol. 9:1174–1178.
2003.PubMed/NCBI
|
|
7
|
Mori Y, Ishiguro H, Kuwabara Y, et al:
Expression of ECRG4 is an independent prognostic factor for poor
survival in patients with esophageal squamous cell carcinoma. Oncol
Rep. 18:981–985. 2007.PubMed/NCBI
|
|
8
|
Li LW, Yu XY, Yang Y, Zhang CP, Guo LP and
Lu SH: Expression of esophageal cancer related gene 4 (ECRG4), a
novel tumor suppressor gene, in esophageal cancer and its
inhibitory effect on the tumor growth in vitro and in vivo. Int J
Cancer. 125:1505–1513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Götze S, Feldhaus V, Traska T, et al:
ECRG4 is a candidate tumor suppressor gene frequently
hypermethylated in colorectal carcinoma and glioma. BMC Cancer.
9:4472009.PubMed/NCBI
|
|
10
|
Vanaja DK, Ehrich M, Van den Boom D, et
al: Hypermethylation of genes for diagnosis and risk stratification
of prostate cancer. Cancer Invest. 27:549–560. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang YB and Ba CF: Promoter methylation of
esophageal cancer-related gene 4 in gastric cancer tissue and its
clinical significance. Hepatogastroenterology. 59:1696–1698.
2012.PubMed/NCBI
|
|
12
|
Matsuzaki J, Torigoe T, Hirohashi Y, et
al: ECRG4 is a negative regulator of caspase-8-mediated apoptosis
in human T-leukemia cells. Carcinogenesis. 33:996–1003. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sabatier R, Finetti P, Adelaide J, et al:
Down-regulation of ECRG4, a candidate tumor suppressor gene, in
human breast cancer. PLoS One. 6:e276562011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li LW, Li YY, Li XY, Zhang CP, Zhou Y and
Lu SH: A novel tumor suppressor gene ECRG4 interacts directly with
TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal
carcinoma. BMC Cancer. 11:522011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Liu Y, Gilcrease MZ, et al: A
lymph node metastatic mouse model reveals alterations of
metastasis-related gene expression in metastatic human oral
carcinoma sublines selected from a poorly metastatic parental cell
line. Cancer. 95:1663–1672. 2002. View Article : Google Scholar
|
|
16
|
Lis R, Capdet J, Mirshahi P, et al:
Oncologic trogocytosis with Hospicells induces the expression of
N-cadherin by breast cancer cells. Int J Oncol. 37:1453–1461.
2010.PubMed/NCBI
|
|
17
|
Tang J, Feng Y, Tsao S, Wang N, Curtain R
and Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic
agents: a review of traditional use and biomedical investigations.
J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Liu X, Zhang B, et al:
Overexpression of candidate tumor suppressor ECRG4 inhibits glioma
proliferation and invasion. J Exp Clin Cancer Res. 29:892010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao JJ, Cheng H, Shidong J, et al: The
p110a isoform of PI3K is essential for proper growth factor
signaling and oncogenic transformation. Proc Natl Acad Sci USA.
103:16296–16300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inoki K, Zhu T and Guan KL: TSC2 mediates
cellular energy response to control cell growth and survival. Cell.
115:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao M, Epstein JB, Modi BJ, Pytynia KB,
Mundt AJ and Feldman LE: Current surgical treatment of squamous
cell carcinoma of the head and neck. Oral Oncol. 43:213–223. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu T, Yu CY, Sun JJ, et al: Bone
morphogenetic protein-4-induced epithelial-mesenchymal transition
and invasiveness through Smad1-mediated signal pathway in squamous
cell carcinoma of the head and neck. Arch Med Res. 42:128–137.
2011. View Article : Google Scholar : PubMed/NCBI
|
